128 related articles for article (PubMed ID: 38127826)
41. Comprehensive Molecular Characterization and Response to Therapy in Fumarate Hydratase-Deficient Renal Cell Carcinoma.
Gleeson JP; Nikolovski I; Dinatale R; Zucker M; Knezevic A; Patil S; Ged Y; Kotecha RR; Shapnik N; Murray S; Russo P; Coleman J; Lee CH; Stadler ZK; Hakimi AA; Feldman DR; Motzer RJ; Reznik E; Voss MH; Chen YB; Carlo MI
Clin Cancer Res; 2021 May; 27(10):2910-2919. PubMed ID: 33658299
[TBL] [Abstract][Full Text] [Related]
42. Papillary renal cell carcinoma: analysis of germline mutations in the MET proto-oncogene in a clinic-based population.
Lindor NM; Dechet CB; Greene MH; Jenkins RB; Zincke MT; Weaver AL; Wilson M; Zincke H; Liu W
Genet Test; 2001; 5(2):101-6. PubMed ID: 11551094
[TBL] [Abstract][Full Text] [Related]
43. Germline Mutations for Novel Candidate Predisposition Genes in Sporadic Schwannomatosis.
Min BJ; Kang YK; Chung YG; Seo ME; Chang KB; Joo MW
Clin Orthop Relat Res; 2020 Nov; 478(11):2442-2450. PubMed ID: 32281771
[TBL] [Abstract][Full Text] [Related]
44. Germline BAP1 mutations predispose to renal cell carcinomas.
Popova T; Hebert L; Jacquemin V; Gad S; Caux-Moncoutier V; Dubois-d'Enghien C; Richaudeau B; Renaudin X; Sellers J; Nicolas A; Sastre-Garau X; Desjardins L; Gyapay G; Raynal V; Sinilnikova OM; Andrieu N; Manié E; de Pauw A; Gesta P; Bonadona V; Maugard CM; Penet C; Avril MF; Barillot E; Cabaret O; Delattre O; Richard S; Caron O; Benfodda M; Hu HH; Soufir N; Bressac-de Paillerets B; Stoppa-Lyonnet D; Stern MH
Am J Hum Genet; 2013 Jun; 92(6):974-80. PubMed ID: 23684012
[TBL] [Abstract][Full Text] [Related]
45. Pathogenic ATM and BAP1 germline mutations in a case of early-onset, familial sarcomatoid renal cancer.
Bell HN; Kumar-Sinha C; Mannan R; Zakalik D; Zhang Y; Mehra R; Jagtap D; Dhanasekaran SM; Vaishampayan U
Cold Spring Harb Mol Case Stud; 2022 Apr; 8(3):. PubMed ID: 35483881
[TBL] [Abstract][Full Text] [Related]
46. Detection Rate and Spectrum of Pathogenic Variations in a Cohort of 83 Patients with Suspected Hereditary Risk of Kidney Cancer.
Ouedraogo ZG; Ceruti F; Lepage M; Gay-Bellile M; Uhrhammer N; Ponelle-Chachuat F; Bidet Y; Privat M; Cavaillé M
Genes (Basel); 2023 Oct; 14(11):. PubMed ID: 38002934
[TBL] [Abstract][Full Text] [Related]
47. Inherited Germline Cancer Susceptibility Gene Variants in Individuals with Non-Muscle-Invasive Bladder Cancer.
Pietzak EJ; Whiting K; Srinivasan P; Bandlamudi C; Khurram A; Joseph V; Walasek A; Bochner E; Clinton T; Almassi N; Truong H; de Jesus Escano MR; Wiseman M; Mandelker D; Kemel Y; Zhang L; Walsh MF; Cadoo KA; Coleman JA; Al-Ahmadie H; Rosenberg JE; Iyer GV; Solit DB; Ostrovnaya I; Offit K; Robson ME; Stadler ZK; Berger MF; Bajorin DF; Carlo M; Bochner BH
Clin Cancer Res; 2022 Oct; 28(19):4267-4277. PubMed ID: 35833951
[TBL] [Abstract][Full Text] [Related]
48. The Impact of Germline Alterations in Appendiceal Adenocarcinoma.
Foote MB; Walch H; Kemel Y; Vakiani E; Johannet P; Sheehan M; Chatila W; Chung S; Nash GM; Maio A; Shia J; Mandelker D; Berger M; Schultz N; Diaz LA; Cercek A; Stadler ZK
Clin Cancer Res; 2023 Jul; 29(14):2631-2637. PubMed ID: 37289003
[TBL] [Abstract][Full Text] [Related]
49. Hereditary Leiomyomatosis and Renal Cell Cancer: Clinical, Molecular, and Screening Features in a Cohort of 185 Affected Individuals.
Forde C; Lim DHK; Alwan Y; Burghel G; Butland L; Cleaver R; Dixit A; Evans DG; Hanson H; Lalloo F; Oliveira P; Vialard L; Wallis Y; Maher ER; Woodward ER
Eur Urol Oncol; 2020 Dec; 3(6):764-772. PubMed ID: 31831373
[TBL] [Abstract][Full Text] [Related]
50. Thai patients who fulfilled NCCN criteria for breast/ovarian cancer genetic assessment demonstrated high prevalence of germline mutations in cancer susceptibility genes: implication to Asian population testing.
Lertwilaiwittaya P; Roothumnong E; Nakthong P; Dungort P; Meesamarnpong C; Tansa-Nga W; Pongsuktavorn K; Wiboonthanasarn S; Tititumjariya W; Thongnoppakhun W; Chanprasert S; Limwongse C; Pithukpakorn M
Breast Cancer Res Treat; 2021 Jul; 188(1):237-248. PubMed ID: 33649982
[TBL] [Abstract][Full Text] [Related]
51. Genomic organization and chromosomal localization of the human CUL2 gene and the role of von Hippel-Lindau tumor suppressor-binding protein (CUL2 and VBP1) mutation and loss in renal-cell carcinoma development.
Clifford SC; Walsh S; Hewson K; Green EK; Brinke A; Green PM; Gianelli F; Eng C; Maher ER
Genes Chromosomes Cancer; 1999 Sep; 26(1):20-8. PubMed ID: 10441001
[TBL] [Abstract][Full Text] [Related]
52. Germline Genetic Features of Young Individuals With Colorectal Cancer.
Stoffel EM; Koeppe E; Everett J; Ulintz P; Kiel M; Osborne J; Williams L; Hanson K; Gruber SB; Rozek LS
Gastroenterology; 2018 Mar; 154(4):897-905.e1. PubMed ID: 29146522
[TBL] [Abstract][Full Text] [Related]
53. The pVHL-associated SCF ubiquitin ligase complex: molecular genetic analysis of elongin B and C, Rbx1 and HIF-1alpha in renal cell carcinoma.
Clifford SC; Astuti D; Hooper L; Maxwell PH; Ratcliffe PJ; Maher ER
Oncogene; 2001 Aug; 20(36):5067-74. PubMed ID: 11526493
[TBL] [Abstract][Full Text] [Related]
54. Diseases of Hereditary Renal Cell Cancers.
Iliopoulos O
Urol Clin North Am; 2023 May; 50(2):205-215. PubMed ID: 36948667
[TBL] [Abstract][Full Text] [Related]
55. Germline mutation in the NBR1 gene involved in autophagy detected in a family with renal tumors.
Adolphe F; Ferlicot S; Verkarre V; Posseme K; Couvé S; Garnier P; Droin N; Deloger M; Job B; Giraud S; Paillerets BB; Gardie B; Richard S; Renaud F; Gad S
Cancer Genet; 2021 Nov; 258-259():51-56. PubMed ID: 34488032
[TBL] [Abstract][Full Text] [Related]
56. Early onset renal cell carcinoma in an adolescent girl with germline FLCN exon 5 deletion.
Schneider M; Dinkelborg K; Xiao X; Chan-Smutko G; Hruska K; Huang D; Sagar P; Harisinghani M; Iliopoulos O
Fam Cancer; 2018 Jan; 17(1):135-139. PubMed ID: 28623476
[TBL] [Abstract][Full Text] [Related]
57. Kidney tumors associated with germline mutations of FH and SDHB show a CpG island methylator phenotype (CIMP).
Ricketts CJ; Killian JK; Vocke CD; Wang Y; Merino MJ; Meltzer PS; Linehan WM
PLoS One; 2022; 17(12):e0278108. PubMed ID: 36455002
[TBL] [Abstract][Full Text] [Related]
58. Clinicopathologic characterization of breast carcinomas in patients with non-BRCA germline mutations: results from a single institution's high-risk population.
Meiss AE; Thomas M; Modesitt SC; Ring KL; Atkins KA; Mills AM
Hum Pathol; 2018 Dec; 82():20-31. PubMed ID: 29958926
[TBL] [Abstract][Full Text] [Related]
59. Exon splicing analysis of intronic variants in multigene cancer panel testing for hereditary breast/ovarian cancer.
Ryu JS; Lee HY; Cho EH; Yoon KA; Kim MK; Joo J; Lee ES; Kang HS; Lee S; Lee DO; Lim MC; Kong SY
Cancer Sci; 2020 Oct; 111(10):3912-3925. PubMed ID: 32761968
[TBL] [Abstract][Full Text] [Related]
60. Germline genetic variants in somatically significantly mutated genes in tumors are associated with renal cell carcinoma risk and outcome.
Shu X; Gu J; Huang M; Tannir NM; Matin SF; Karam JA; Wood CG; Wu X; Ye Y
Carcinogenesis; 2018 May; 39(6):752-757. PubMed ID: 29635281
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]